Phenyl chloroformate → HCID 15603610, compound
Reaction equation
[NH:1]1[CH2:6][CH2:5][CH:4]([CH2:7][N:8]2[CH2:13][CH2:12][CH:11]([CH2:14][NH:15][C:16]([C:18]3[C:26]4[N:25]=[C:24]([CH:27]([CH3:29])[CH3:28])[NH:23][C:22]=4[CH:21]=[CH:20][CH:19]=3)=[O:17])[CH2:10][CH2:9]2)[CH2:3][CH2:2]1.C(N(CC)C(C)C)(C)C.Cl[C:40]([O:42][C:43]1[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=1)=[O:41]>ClCCl>[C:43]1([O:42][C:40]([N:1]2[CH2:2][CH2:3][CH:4]([CH2:7][N:8]3[CH2:9][CH2:10][CH:11]([CH2:14][NH:15][C:16]([C:18]4[C:26]5[N:25]=[C:24]([CH:27]([CH3:29])[CH3:28])[NH:23][C:22]=5[CH:21]=[CH:20][CH:19]=4)=[O:17])[CH2:12][CH2:13]3)[CH2:5][CH2:6]2)=[O:41])[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 2-isopropyl-1H-benzoimidazole-4-carboxylic acid (1-piperidin-4-ylmethylpiperidin-4-ylmethyl)amide (0.22 g, 0.55 mmol) and N,N-diisopropylethylamine (0.19 mL) in dichloromethane (5.0 mL) was added phenyl chloroformate (70 μL). The mixture was stirred at room temperature for 10 min, then concentrated in vacuo and purified via preparative reverse phase HPLC to afford the bis trifluoroacetate salt of the title compound as a white solid (98.4 mg, 0.13 mmol, 24%). (m/z): [M+H]+ calcd for C30H39N5O3 518.32; found 518.6. 1H NMR (300 MHz, MeOD-d3): δ (ppm) 1.14-1.28 (m, 2H), 1.39-1.53 (m, 6H), 1.52-1.62 (m, 2H), 1.70-1.78 (m, 2H), 1.92-2.06 (m, 4H), 2.82-2.97 (m, 6H), 3.32-3.38 (m, 2H), 3.43-3.50 (m, 1H), 3.52-3.69 (m, 2H), 4.04-4.12 (m, 1H), 4.18-4.26 (m, 1H), 6.91-6.98 (m, 1H), 7.08-7.13 (m, 1H), 7.21-7.28 (m, 1H), 7.45-7.50 (m, 1H), 7.73-7.77 (m, 1H), 7.81-7.87 (m, 1H), 9.02-9.32 (brs, 1H).
Workup
- concentrationconcentrated in vacuo
- custompurified via preparative reverse phase HPLC
Sources & evidence
- ORD record
- ord-217992a9b96e4481a95174ab1ca1cde5
- Source dataset
- uspto-grants-2010_07
- Patent number
- US07759363B2
Reaction notes
Loading…